Seratrodast

DB06739ExperimentalSmall molecule

Seratrodast (INN) is a thromboxane receptor antagonist used primarily in the treatment of asthma.

Chemical structure of Seratrodast
Mechanism
Curator reviewed
Formula / weight
C22H26O4 · 354.446 g/mol (avg)
Code names
A-73001 · AA-2414 · ABBOTT-73001 · ABT-001

Resolves to

Compound
UNII4U58JM421NCAS112665-43-7ChEMBLCHEMBL70972ChEBI32126PubChem2449KEGGD01123
Clinical / RWD
ATCR03DX06
Structure
InChIKeyZBVKEHDGYSLCCC-UHFFFAOYSA-NSMILESCC1=C(C)C(=O)C(C(CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
Targets
P21731TBXA2R

What you can answer from here — as of August 26, 2024

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
701Drug interactionsStructured to mechanism, not free text
Sign in
1ATC codeIncluding every combination product, plus 30 drug categories
Sign in
21+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Seratrodast, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In